Femasys Inc. (NASDAQ:FEMY) Short Interest Up 64.2% in August

Femasys Inc. (NASDAQ:FEMY) saw a significant increase in short interest during the month of August. As of August 14th, there was short interest totaling 434,999 shares, an increase of 64.2% from the July 30th total of 264,928 shares. Based on an average daily trading volume, of 274,553 shares, the short-interest ratio is currently 1.6 days. Currently, 5.6% of the shares of the company are short sold.

Insider Buying and Selling

In other Femasys news, CEO Kathy Lee-Sepsick bought 15,625 shares of Femasys stock in a transaction dated Friday, August 7th. The stock was bought at an average cost of $3.20 per share, for a total transaction of $50,000.00. Following the purchase, the chief executive officer owned 15,625 shares of the company’s stock, valued at $50,000. The trade was a ? increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Dov Elefant bought 15,625 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were acquired at an average cost of $3.20 per share, for a total transaction of $50,000.00. Following the completion of the acquisition, the chief financial officer directly owned 15,625 shares in the company, valued at $50,000. The trade was a ? increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders bought 38,750 shares of company stock valued at $124,000. Insiders own 7.75% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Cetera Investment Advisers bought a new stake in shares of Femasys in the 4th quarter valued at about $36,000. Kovack Advisors Inc. acquired a new position in shares of Femasys in the fourth quarter worth approximately $27,000. State Street Corp boosted its holdings in Femasys by 43.5% in the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock valued at $47,000 after acquiring an additional 24,500 shares during the last quarter. Jane Street Group LLC bought a new stake in Femasys in the fourth quarter valued at approximately $62,000. Finally, HRT Financial LP acquired a new stake in Femasys during the 4th quarter valued at approximately $30,000. 65.27% of the stock is owned by institutional investors and hedge funds.

Femasys Price Performance

Shares of FEMY stock traded up $0.23 during trading hours on Monday, reaching $3.43. The company’s stock had a trading volume of 227,000 shares, compared to its average volume of 302,278. Femasys has a fifty-two week low of $2.02 and a fifty-two week high of $22.20. The company has a quick ratio of 0.55, a current ratio of 2.14 and a debt-to-equity ratio of 0.89. The firm’s 50 day simple moving average is $3.25 and its 200-day simple moving average is $6.72. The company has a market capitalization of $28.73 million, a price-to-earnings ratio of -0.97 and a beta of -2.08.

Femasys (NASDAQ:FEMY) last announced its quarterly earnings results on Friday, August 14th. The company reported ($1.33) EPS for the quarter, missing analysts’ consensus estimates of ($1.31) by ($0.02). Femasys had a negative net margin of 534.36% and a negative return on equity of 225.97%. The firm had revenue of $0.33 million during the quarter, compared to the consensus estimate of $0.73 million.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on FEMY. Maxim Group decreased their price target on shares of Femasys to $10.00 and set a “buy” rating on the stock in a research note on Friday, August 14th. Wall Street Zen downgraded Femasys from a “hold” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings lowered Femasys from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, August 17th. Finally, Lake Street Capital decreased their price objective on Femasys to $10.00 and set a “buy” rating on the stock in a report on Tuesday, August 18th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $50.00.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.